OpenAlex
PricingAboutJobs
Log inGet started
Work

Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Gut
DOI: 10.1136/gut.2010.225482
Authors: Keith Leiper, Kate Martin, Anthony Ellis, Sreedhar Subramanian, Alastair J Watson, Steve E Christmas, Deborah Howarth, Fiona Campbell, Jonathan M Rhodes
Institutions: Royal Liverpool University Hospital, University of Liverpool
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: rituximab, anti-CD20 monoclonal antibody, ulcerative colitis, B-cell depletion, remission, mucosal healing, Mayo score, corticosteroid withdrawal, azathioprine, methotrexate, 6-mercaptopurine, infusion reactions, drug safety, immunosuppressive therapy, inflammatory bowel disease treatment, relapse
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2125618377
FWCI: 10.27
Cites: 32
Cited by: 189
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms